MedDataX Logo

Effects of Continuous Venous Dialysis and Hemodialysis on Fluid Dynamics by Bioreactance Method

NCT ID: NCT03905122

Last Updated: 2020-10-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

60 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-06-15

Study Completion Date

2020-06-15

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Dialysis methods applied at the bedside and dialysis methods applied in hemodialysis unit are widely applied in patients with renal insufficiency. Especially hemodynamically affected patients are less affected by hemodynamics as a result of using dialysis methods. It is a completely non-invasive method by bioreactance method and it can be done to measure the intra-body fluid status with the help of the glued probes. The aim of this study is to investigate the effects of continuous venous dialysis and hemodialysis on the fluid dynamics applied at the bedside with bioreactance method. In this way, the patient can develop more comfortable hemodynamic changes. Patients in the Surgery, Reanimation and Postoperative Intensive Care Unit with more than 24 hours of hospitalization and bedside dialysis or hemodialysis will be included in the study. Before the dialysis, body fluid measurements will be made with bioreactance, and after dialysis in patients receiving hemodialysis, and in dialysis patients 6, 12, 24 and 36 hours.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Effect of Dialysis Membranes on Inflammatory and Immune Processes in Hemodialysis

NCT03836508

Kidney Failure Renal Insufficiency, Chronic Dialysis Related Complication
COMPLETED NA

Evaluation of a Bioimpedance Method for Determination of Dry Weight in Dialysis Patients

NCT00397306

Renal Insufficiency, Chronic
COMPLETED NA

Evaluating the Effect of the Valsalva Maneuver on Invasive Pain During Arteriovenous Fistula Cannulation in Hemodialysis Patients

NCT07066579

Arteriovenous Fistula Pain Hemodialysis Access Failure +1 more
NOT_YET_RECRUITING NA

Temperature and Bicarbonate: Hemodynamic Effects During Dialysis

NCT05052151

End Stage Renal Disease on Dialysis
COMPLETED NA

Reduction of Microemboli of Air Using a New Developed Air Trap (EmbolessTM) During Haemodialysis

NCT06168539

Hemodialysis Complication Air Embolism Extracorporeal Circulation; Complications
COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Dialysis methods applied at the bedside and dialysis methods applied in hemodialysis unit are widely applied in patients with renal insufficiency. Especially hemodynamically affected patients are less affected by hemodynamics as a result of using dialysis methods. Dialysis in the hemodialysis unit is a method used in intensive care patients and is preferred especially in patients with stable hemodynamics. In dialysis methods, changes occur frequently in the body fluids of the patient. It is a completely non-invasive method by bioreactance method and it can be done to measure the intra-body fluid status with the help of the glued probes. The aim of this study is to investigate the effects of continuous venous dialysis and hemodialysis on the fluid dynamics applied at the bedside with bioreactance method. As a result of measurements with buioreactans method, fluid balance in patients will be understood more easily. In this way, the patient can develop more comfortable hemodynamic changes. Patients in the Surgery, Reanimation and Postoperative Intensive Care Unit with more than 24 hours of hospitalization and bedside dialysis or hemodialysis will be included in the study. Before the dialysis, body fluid measurements will be made with bioreactance, and after dialysis in patients receiving hemodialysis, and in dialysis patients 6, 12, 24 and 36 hours.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Renal Dialysis

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

continous veno-venous hemodialysis

to measure the fluid changes by using bioreactance method in continous veno-venous hemodialysis group

bioreactans tool

Intervention Type DEVICE

It is a completely non-invasive method by bioreactance method and it can be done to measure the intra-body fluid status with the help of the probes.

hemodialysis

to measure the fluid changes by using bioreactance method in hemodialysis group

bioreactans tool

Intervention Type DEVICE

It is a completely non-invasive method by bioreactance method and it can be done to measure the intra-body fluid status with the help of the probes.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

bioreactans tool

It is a completely non-invasive method by bioreactance method and it can be done to measure the intra-body fluid status with the help of the probes.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* patients required dialysis therapy

Exclusion Criteria

* under 18 years old
* confirmed or undiagnosed brain death
Minimum Eligible Age

18 Years

Maximum Eligible Age

90 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Trakya University

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Prof Mehmet Turan Inal

Clinical Proffessor

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Ahmet Senol Uyar, Specialist

Role: PRINCIPAL_INVESTIGATOR

Trakya University, Edirne

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Trakya University

Edirne, , Turkey (Türkiye)

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Turkey (Türkiye)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

TUTF-BAEK 2018/229

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Immunomodulatory Biomimetic Device to Treat Myocardial Stunning in End-stage Renal Disease Patients
NCT03539861 TERMINATED NA
Effect of Sodium and UF Profiling on Dialysis
NCT06213129 NOT_YET_RECRUITING
Impact of Stress Balls on Cannulation Pain in Hemodialysis: A Randomized Study
NCT06237738 COMPLETED NA
A Prospective Randomized Controlled Trial of Effect of Enhanced External Counter Pulsation to Arterial Stiffness in Chronic Hemodialysis Patient
NCT06608953 ENROLLING_BY_INVITATION NA
Arteriovenous Fistula Cannulation Pain and Skin Cooling Device
NCT06588114 NOT_YET_RECRUITING NA
Effect of Bevel Position of the Artery Needle on Puncture Pain and Post-puncture Bleeding Time
NCT05115448 COMPLETED NA
Multiple Interventions Related to Dialysis Procedures in Order to Reduce Cardiovascular Morbidity and Mortality in HD Patients(EGESTUDY)
NCT00295191 COMPLETED PHASE4
Modulation of Inflammation by Medium Cut Off Membranes
NCT03270371 UNKNOWN NA
Bionenergetic Balance During CVVH
NCT06483542 ACTIVE_NOT_RECRUITING
The Effect of Coolsense Method on Pain and Comfort in Hemodialysis Patients
NCT06144801 COMPLETED NA
Uremic Toxin Removal and Hemodynamics in Long-hour Hemodialysis and Hemodiafiltration
NCT01328119 COMPLETED NA
Dialysis Performance of Different Dialyzer Membranes Using Different Coagulation Strategies
NCT03820401 COMPLETED NA
Investigation of the Effects of Medium Cut-off Dialyzers Versus High-Flux Dialyzers on Clinical and Laboratory Parameters of Prevalent Hemodialysis Patients
NCT05698420 COMPLETED
Application of Citrate Dialysate in Chronic Haemodialysis
NCT01532297 COMPLETED NA
Tolerance to Hemodialysis in Insulin-Requiring Diabetic Patients: BD vs AFB With Blood Volume Biofeedback
NCT01098149 COMPLETED NA
Functionality of Albumin in the Context of Hemodialysis
NCT06561191 RECRUITING NA
A Comparative Study of Two Kinds of Hemodialysis Filters
NCT05899283 COMPLETED NA
Impact of Residual Renal Function on Complications in Chronic Hemodialysis Patients
NCT03854513 UNKNOWN
Changes in Volumetric Hemodynamic Parameters Induced by Fluid Removal on Hemodialysis
NCT02485782 COMPLETED
Audiobook Application in Patients Receiving Hemodialysis Treatment
NCT05272891 COMPLETED NA
Target Weight Correction and Vascular Stiffness in Hemodialysis Patients
NCT03929471 COMPLETED NA
Fluid Management Guided by Bioimpedance Analysis in Peritoneal Dialysis(PD) Patients.
NCT02000128 COMPLETED NA
Peridialysis Project: The Influence of Predialysis Factors on the Initial Course of Dialysis
NCT02488200 UNKNOWN
BIS-guided Fluid Management in HD Patients
NCT05272800 COMPLETED NA
Clinical and Biochemical Effects of Multipass Hemodialysis
NCT01267760 COMPLETED PHASE2